Actively Recruiting
Remote Stimulation and Training to Advance Recovery From TBI in Seniors
Led by Minneapolis Veterans Affairs Medical Center · Updated on 2026-01-12
40
Participants Needed
1
Research Sites
84 weeks
Total Duration
On this page
Sponsors
M
Minneapolis Veterans Affairs Medical Center
Lead Sponsor
C
Center for Veterans Research and Education
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if combining brain stimulation with cognitive training can improve thinking skills in older adults who have had a traumatic brain injury (TBI). The main questions are: * Does transcranial direct current stimulation (tDCS) make cognitive training more effective for improving attention, memory, and decision-making? * Is this type of home-based program feasible and acceptable for older adults with TBI? Researchers will compare two groups: one group will receive active tDCS during cognitive training, and the other group will receive sham (placebo) tDCS during cognitive training. Participants will: * Complete computer-based cognitive training exercises (BrainHQ) to practice attention, memory, and decision-making. * Receive either active or sham tDCS during training sessions. * Complete assessments before and after the program to measure changes in thinking and daily functioning.
CONDITIONS
Official Title
Remote Stimulation and Training to Advance Recovery From TBI in Seniors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Veterans age 65 and older
- History of mild traumatic brain injury sustained at least 3 months prior to enrollment
- Self-reported or medically documented attention or concentration difficulties
- Stable dose of medications affecting cognition or brain chemistry for at least 3 weeks before baseline
- Capable and willing to provide informed consent
You will not qualify if you...
- Medical, psychiatric, or physical conditions posing significant risk or likely to prevent study completion, including history of brain tumor near stimulation site, brain surgery, stroke with current effects, epilepsy, multiple sclerosis, Huntington's Disease, ALS, ataxia, aphasia, Alzheimer's Disease, or dementia
- Moderate to severe cognitive impairment with MoCA score less than 15
- Treatment with ECT or neuromodulation in the last 12 months
- Severe alcohol or substance use disorder with recent withdrawal or tolerance in past 6 months
- Psychosis or mania within 30 days of enrollment
- Contraindications for tDCS such as metallic cranial implants or scalp lesions near electrode site
- No or limited internet connection at home
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Minneapolis VA Health Care System
Minneapolis, Minnesota, United States, 55417
Actively Recruiting
Research Team
C
Casey S Gilmore, PhD
CONTACT
L
Laura Hemmy, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here